HIV-1 suppression and rare dolutegravir resistance in antiretroviral-experienced people with HIV in Liberia
Most participants in the cohort are virologically-suppressed. Among those with virologic failure, HIVDR prevalence is high to NRTIs and NNRTIs, but low to InSTIs. Ongoing evaluation is necessary to determine the durability of DTG-based ART.
Authors
- Robin Dewar (ORCID: https://orcid.org/0000-0002-7840-3155)
- Christina Lindan (ORCID: https://orcid.org/0000-0002-3777-8209)
- Jeffrey N. Martin (ORCID: https://orcid.org/0000-0002-9773-3256)
- David V. Glidden (ORCID: https://orcid.org/0000-0001-5888-1419)
- Weizhong Chang (ORCID: https://orcid.org/0000-0002-1413-2763)
- Tracey Miller
- April Poole (ORCID: https://orcid.org/0000-0003-0767-4334)
- Ian Wachekwa
- Stephen A. Migueles (ORCID: https://orcid.org/0000-0002-6062-8022)
- Kumblytee Johnson (ORCID: https://orcid.org/0000-0003-0437-5398)
- Safia Kuriakose (ORCID: https://orcid.org/0009-0001-4076-6276)
- Moses J Soka (ORCID: https://orcid.org/0000-0001-5773-5292)
- Barthalomew Wilson
- Alice K. Pau (ORCID: https://orcid.org/0000-0002-0153-0236)
- Cavan Reilly (ORCID: https://orcid.org/0000-0002-6695-9113)
- Brad T. Sherman (ORCID: https://orcid.org/0000-0001-5815-7359)
- Jeffrey Scott McCullough (ORCID: https://orcid.org/0000-0001-6155-980X)
- Esther Akpa
- Joseph Dorbor
- Muhammad Attique Khan (ORCID: https://orcid.org/0000-0002-6347-4890)
- Ophelia Talweh Bongolee (ORCID: https://orcid.org/0009-0002-6125-3928)
- Lisheng Dai
- Stacy L. Kopka
- Helene Highbarger
- Greg Grandits
- Moses Mannah
- Carla Chorley
- Isaac Morlu
- Rebecca Slewion
- Cecelia J Nuta
Institutions
- American Medical Informatics Association (US)
- National Institutes of Health (US)
- University of Minnesota (US)
- University of Liberia (LR)
- University of California, San Francisco (US)
- Planned Parenthood Association of Liberia (LR)
- Western Laboratories (United States) (US)
- Frederick National Laboratory for Cancer Research (US)
- National Institute of Allergy and Infectious Diseases (US)
Publication Details
- Journal
- Communications Medicine
- Published
- 2025-05-09
- DOI
- https://doi.org/10.1038/s43856-025-00875-x
- Citations
- 1
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- U.S. Department of Health and Human Services
- National Institutes of Health
- University of California, San Francisco
- National Institute of Mental Health
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases
- Fogarty International Center
- Office of Extramural Research, National Institutes of Health
- NHLBI Division of Intramural Research